The Coronavirus disease 2019 (COVID-19) pandemic poses a great threat to global public
health. The original wild-type strain of severe acute respiratory syndrome coronavirus 2 …

The epidemic curve of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
silently rising again. Worldwide, the dominant SARS-CoV-2 variant of concern (VOC) is …

SARS-CoV-2 is associated with broad tissue tropism, a characteristic often determined by
the availability of entry receptors on host cells. Here, we show that TMEM106B, a lysosomal …

Multiple variants of SARS-CoV-2 have emerged and are now prevalent at the global level.
Currently designated variants of concern (VOCs) are B. 1.1. 7, B1. 351, P. 1, B. 1.617. 2 …

Abstract Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2, continues to be a global concern. Traditional Chinese medicines …

Abstract Coxsackievirus B3 (CVB3) is a viral pathogen of various human disorders with no
effective preventative interventions. Herein, we aimed to design a chimeric vaccine construct …

Coxsackievirus B (CVB) is one of the major viral pathogens of human myocarditis and
cardiomyopathy without any effective preventive measures; therefore, it is necessary to …

In this perspective article, we describe the current status of lipid tools for studying host lipid–
virus interactions at the cellular level. We discuss the potential lipidomic changes that viral …

Since the emergence of SARS-CoV-2 at Wuhan in the Hubei province of China in 2019, the
virus has accumulated various mutations, giving rise to many variants. According to the …

SARS-CoV-2 (severe acute respiratory syndrome) is highly infectious and causes severe
acute respiratory distress syndrome (SARD), immune suppression, and multi-organ failure …